GLP-1 Medications and LASIK: How Semaglutide and Tirzepatide Affect Your Candidacy

The GLP-1 Boom Meets the LASIK Consultation Room

More than 30 million prescriptions for GLP-1 receptor agonists were written in the United States in 2025 alone. Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) have reshaped weight management and type-2 diabetes treatment — and they are increasingly showing up in pre-operative eye exams.

If you are currently taking a GLP-1 medication and considering LASIK, PRK, SMILE, or ICL surgery in Colombia, the conversation is not whether these drugs disqualify you. In most cases, they do not. The conversation is about what changed in your tear film, how rapidly your prescription may still be shifting, and what additional screening your surgeon should perform before giving a green light.

This article covers the emerging clinical evidence, the specific screening adjustments a careful surgeon will make, and the practical timelines you should plan around.

What GLP-1 Drugs Do to the Tear Film

GLP-1 receptors are not limited to the gut and pancreas. They are expressed in lacrimal gland tissue, meibomian glands, and corneal epithelial cells. When you introduce a systemic GLP-1 agonist, you are altering signaling pathways in tissues that directly govern tear production and tear quality.

The clinical picture reported in ophthalmology literature and conference presentations through early 2026 includes three overlapping effects:

Reduced basal tear secretion. Several case series have documented decreased Schirmer test values in patients on semaglutide for six months or longer. The mechanism appears to involve altered parasympathetic signaling to the lacrimal gland, though large controlled studies are still in progress.

Meibomian gland changes. Rapid weight loss — particularly above 15–20% of body weight — can change the lipid composition of meibomian gland secretions. The oily layer of the tear film thins, tears evaporate faster, and patients report grittiness, burning, and fluctuating vision even before any surgical procedure.

Refractive instability from weight flux. Significant weight change — in either direction — can shift corneal curvature and crystalline lens hydration. A prescription measured during active weight loss may not represent the prescription you will stabilize at. This is not unique to GLP-1 drugs; it has been documented in bariatric surgery patients for decades. But the speed and prevalence of GLP-1-driven weight loss has made it a much more common pre-LASIK scenario.

Does This Mean GLP-1 Patients Cannot Get LASIK?

No. There is no blanket contraindication. The question is timing and screening depth.

A responsible refractive surgeon — in Colombia or anywhere — will want to see two things before scheduling your procedure:

Prescription stability. At least two refractions, taken three to six months apart, that match within 0.50 diopters. If you are still losing weight, your prescription may still be moving. Most surgeons will ask you to reach your target weight and hold it for three to six months before locking in a surgical plan.

Tear film adequacy. A thorough dry-eye workup — not just a Schirmer strip and a quick slit-lamp look, but tear breakup time (TBUT), meibography, osmolarity testing if available, and a symptom questionnaire (OSDI or DEQ-5). If your tear film is compromised, the surgeon may recommend a pre-treatment protocol (preservative-free artificial tears, omega-3 supplementation, warm compresses, possibly IPL or punctal plugs) for four to eight weeks before clearing you.

The Weight-Stability Timeline

This is the part most patients do not want to hear: if you are still in an active dose-titration phase or still losing more than one to two pounds per week, most careful surgeons will ask you to wait.

The wait is not arbitrary. Corneal curvature changes of 0.25 to 0.75 diopters have been documented during rapid weight loss. If your surgeon ablates tissue based on measurements taken during that flux, your final result could undershoot or overshoot the target. Enhancement rates are higher in populations with unstable refractions — and an enhancement means a second procedure, additional tissue removal, and additional recovery time.

The practical guidance that has emerged from refractive surgeons who see high volumes of post-weight-loss patients:

If you have reached your goal weight and your weight has been stable (within five pounds) for three months, you can begin the screening process. If two refractions three months apart are within 0.50 diopters, you are likely safe to proceed.

If you are still in active weight loss, complete the weight-loss phase first. The surgery will still be there. The typical LASIK cost in Colombia — $1,200 to $2,200 for both eyes, depending on technology — is not going anywhere. Waiting three to six months to ensure a stable, accurate result is almost always the right call.

Which Procedure Is Best for GLP-1 Patients with Dry Eye?

If your screening reveals borderline or mild dry eye that responds well to a pre-treatment protocol, standard LASIK (with a femtosecond flap) remains a viable option. The dry-eye effect of a LASIK flap is temporary in most patients and resolves within three to six months.

If your dry eye is moderate or your meibomian glands show structural dropout on meibography, your surgeon may recommend one of the flapless alternatives:

SMILE or SMILE Pro. The smaller incision (2–4mm vs. 20mm flap) disrupts fewer corneal nerves. Published data shows lower rates of post-operative dry eye compared to LASIK at three and six months. If your prescription falls within the SMILE correction range (up to roughly -10 diopters of myopia, up to -5 diopters of astigmatism), this may be the better fit.

PRK. No flap, no lenticule extraction — surface ablation only. Corneal nerve recovery is slower in the first weeks but more complete long-term. PRK is worth discussing if dry eye is a primary concern, though recovery takes longer (blurry vision for several days, full stabilization over one to three months).

ICL (EVO Visian ICL). No corneal tissue removal at all. The lens is placed behind the iris and in front of the crystalline lens. Zero corneal nerve disruption. If your dry eye is significant and you also have a high prescription (-6 and above), ICL sidesteps the dry-eye question entirely. Colombia pricing for ICL typically runs $2,400 to $3,800 for both eyes — roughly one-third of US pricing.

What to Tell Your Surgeon

When you book a consultation — whether in Medellín, Bogotá, or anywhere else — come prepared with the following:

Your medication list including the specific GLP-1 drug, your current dose, how long you have been on it, and whether your dose has changed recently.

Your weight trajectory. Your approximate starting weight, current weight, and whether you are still actively losing or have plateaued. Surgeons are not judging — they are calibrating.

Your most recent eye prescription from your home optometrist or ophthalmologist, with the date it was measured. If you have an older prescription (from before starting the GLP-1), bring that too. The comparison tells the surgeon whether your refraction shifted.

Any dry-eye symptoms you have noticed since starting the medication: morning dryness, fluctuating vision (especially later in the day or after screen time), burning, foreign-body sensation.

A thorough Colombian refractive surgeon will take it from there. The consultation typically runs 90 minutes to two hours and includes corneal topography, pachymetry, wavefront analysis, pupillometry, and a full anterior-segment exam — plus the dry-eye workup described above. In most Medellín and Bogotá clinics, the consultation fee runs $50 to $150 and is often credited toward the procedure if you proceed.

The Bottom Line

GLP-1 medications do not disqualify you from LASIK, SMILE, PRK, or ICL. But they do change the screening your surgeon needs to perform and the timeline you should plan around. The two non-negotiable requirements are prescription stability (confirmed by serial refractions after weight stabilization) and tear-film adequacy (confirmed by a comprehensive dry-eye workup, with pre-treatment if needed).

Colombia's refractive surgery clinics — particularly in Medellín and Bogotá — perform thousands of procedures annually on international patients, many of whom arrive with complex pre-operative profiles. A screening that takes GLP-1 use seriously is a sign of a clinic that does things right, not one that is trying to find reasons to turn you away.

If you are currently on a GLP-1 medication and want to know where you stand, a virtual pre-screening can answer most of the initial questions before you book a flight.